$3.41
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Trevi Therapeutics (TRVI) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTrevi Therapeutics (NASDAQ:TRVI) Stock Quotes, Forecast and News Summary
Trevi Therapeutics Stock (NASDAQ: TRVI) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 234.44K |
| Day Range | - - - |
| 52 Wk Range | 0.97 - 4.00 |
| Market Cap | $247.54M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 62 |
| Short Interest | 3.43% |
| Days to Cover | 12.93 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Trevi Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Trevi Therapeutics (TRVI) stock?
You can purchase shares of Trevi Therapeutics (NASDAQ:TRVI) through any online brokerage.
Who are Trevi Therapeutics (TRVI) competitors?
Other companies in Trevi Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and Xeris Biopharma Holdings (NASDAQ:XERS).
What is the forecast, or price target, for Trevi Therapeutics (TRVI) stock?
Trevi Therapeutics has a consensus price target of $8.73.
What is the current price for Trevi Therapeutics (TRVI)?
The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $3.41 last updated September 18, 2024 at 4:00 PM EDT.
Does Trevi Therapeutics (TRVI) pay a dividend?
There are no upcoming dividends for Trevi Therapeutics.
When is Trevi Therapeutics (NASDAQ:TRVI) reporting earnings?
Trevi Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Trevi Therapeutics (TRVI) going to split?
There is no upcoming split for Trevi Therapeutics.
What sector and industry does Trevi Therapeutics (TRVI) operate in?
Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.